CN105231247A - 一种果蔬多维保健泡腾片及其制备方法 - Google Patents
一种果蔬多维保健泡腾片及其制备方法 Download PDFInfo
- Publication number
- CN105231247A CN105231247A CN201510542106.9A CN201510542106A CN105231247A CN 105231247 A CN105231247 A CN 105231247A CN 201510542106 A CN201510542106 A CN 201510542106A CN 105231247 A CN105231247 A CN 105231247A
- Authority
- CN
- China
- Prior art keywords
- parts
- effervescent tablet
- fruit
- health
- fruits
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007938 effervescent tablet Substances 0.000 title claims abstract description 65
- 235000012055 fruits and vegetables Nutrition 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims description 13
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 33
- 244000226021 Anacardium occidentale Species 0.000 claims abstract description 25
- 235000020226 cashew nut Nutrition 0.000 claims abstract description 25
- 239000000945 filler Substances 0.000 claims abstract description 23
- 240000000560 Citrus x paradisi Species 0.000 claims abstract description 21
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims abstract description 19
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 19
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 19
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 19
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 19
- 239000000314 lubricant Substances 0.000 claims abstract description 19
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims abstract description 18
- 240000003768 Solanum lycopersicum Species 0.000 claims abstract description 18
- 210000002826 placenta Anatomy 0.000 claims abstract description 16
- 240000003705 Senecio vulgaris Species 0.000 claims abstract description 15
- 235000021307 Triticum Nutrition 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 244000098338 Triticum aestivum Species 0.000 claims abstract 3
- 239000000843 powder Substances 0.000 claims description 35
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 30
- 230000036541 health Effects 0.000 claims description 30
- 235000013399 edible fruits Nutrition 0.000 claims description 25
- 244000298715 Actinidia chinensis Species 0.000 claims description 18
- 235000009434 Actinidia chinensis Nutrition 0.000 claims description 18
- 235000021028 berry Nutrition 0.000 claims description 18
- 239000007884 disintegrant Substances 0.000 claims description 17
- 239000000284 extract Substances 0.000 claims description 16
- 235000018905 epimedium Nutrition 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 15
- 241000233866 Fungi Species 0.000 claims description 14
- 230000009194 climbing Effects 0.000 claims description 14
- 241001016310 Epimedium grandiflorum Species 0.000 claims description 13
- 244000241872 Lycium chinense Species 0.000 claims description 13
- 235000015468 Lycium chinense Nutrition 0.000 claims description 13
- 235000009508 confectionery Nutrition 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000003814 drug Substances 0.000 claims description 12
- 238000005507 spraying Methods 0.000 claims description 12
- 235000020985 whole grains Nutrition 0.000 claims description 12
- 229960004106 citric acid Drugs 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 9
- 239000003826 tablet Substances 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 8
- 235000013311 vegetables Nutrition 0.000 claims description 8
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 7
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 7
- 239000001630 malic acid Substances 0.000 claims description 7
- 235000011090 malic acid Nutrition 0.000 claims description 7
- 238000000227 grinding Methods 0.000 claims description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 5
- 235000013339 cereals Nutrition 0.000 claims description 5
- 239000008101 lactose Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 229960003511 macrogol Drugs 0.000 claims description 5
- 244000000626 Daucus carota Species 0.000 claims description 4
- 235000002767 Daucus carota Nutrition 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 240000000950 Hippophae rhamnoides Species 0.000 claims description 4
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims description 4
- 239000006286 aqueous extract Substances 0.000 claims description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 4
- CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 4
- 239000011122 softwood Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 235000014101 wine Nutrition 0.000 claims description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 3
- 229940037627 magnesium lauryl sulfate Drugs 0.000 claims description 3
- HBNDBUATLJAUQM-UHFFFAOYSA-L magnesium;dodecyl sulfate Chemical compound [Mg+2].CCCCCCCCCCCCOS([O-])(=O)=O.CCCCCCCCCCCCOS([O-])(=O)=O HBNDBUATLJAUQM-UHFFFAOYSA-L 0.000 claims description 3
- TZBAVQKIEKDGFH-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]-1-benzothiophene-2-carboxamide;hydrochloride Chemical compound [Cl-].C1=CC=C2SC(C(=O)NCC[NH+](CC)CC)=CC2=C1 TZBAVQKIEKDGFH-UHFFFAOYSA-N 0.000 claims description 3
- 239000011975 tartaric acid Substances 0.000 claims description 3
- 235000002906 tartaric acid Nutrition 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 239000004411 aluminium Substances 0.000 claims description 2
- 229910052782 aluminium Inorganic materials 0.000 claims description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 2
- 229960004543 anhydrous citric acid Drugs 0.000 claims description 2
- 229940099690 malic acid Drugs 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 229960001367 tartaric acid Drugs 0.000 claims description 2
- 208000020670 canker sore Diseases 0.000 claims 1
- 210000004185 liver Anatomy 0.000 abstract description 14
- 229940088594 vitamin Drugs 0.000 abstract description 9
- 239000011782 vitamin Substances 0.000 abstract description 9
- 230000036039 immunity Effects 0.000 abstract description 8
- 229930003231 vitamin Natural products 0.000 abstract description 8
- 235000013343 vitamin Nutrition 0.000 abstract description 8
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 7
- 239000011707 mineral Substances 0.000 abstract description 7
- 230000004438 eyesight Effects 0.000 abstract description 6
- 241000202807 Glycyrrhiza Species 0.000 abstract description 2
- 244000241838 Lycium barbarum Species 0.000 abstract description 2
- 235000015459 Lycium barbarum Nutrition 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 235000012907 honey Nutrition 0.000 abstract description 2
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 abstract description 2
- 235000014571 nuts Nutrition 0.000 abstract description 2
- 230000001502 supplementing effect Effects 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract 2
- 244000298697 Actinidia deliciosa Species 0.000 abstract 1
- 241000219071 Malvaceae Species 0.000 abstract 1
- 241001506047 Tremella Species 0.000 abstract 1
- 235000013312 flour Nutrition 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 14
- 235000019640 taste Nutrition 0.000 description 13
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 12
- 241000209140 Triticum Species 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 10
- 239000011575 calcium Substances 0.000 description 10
- 229910052791 calcium Inorganic materials 0.000 description 10
- 235000001465 calcium Nutrition 0.000 description 10
- 210000003734 kidney Anatomy 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 9
- 235000016709 nutrition Nutrition 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 229930003268 Vitamin C Natural products 0.000 description 6
- 235000010755 mineral Nutrition 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 235000019154 vitamin C Nutrition 0.000 description 6
- 239000011718 vitamin C Substances 0.000 description 6
- 150000003722 vitamin derivatives Chemical class 0.000 description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 235000019155 vitamin A Nutrition 0.000 description 5
- 239000011719 vitamin A Substances 0.000 description 5
- 229940045997 vitamin a Drugs 0.000 description 5
- 239000011701 zinc Substances 0.000 description 5
- 229910052725 zinc Inorganic materials 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 235000001727 glucose Nutrition 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 208000012287 Prolapse Diseases 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- -1 carrotene Chemical compound 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000010411 cooking Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- CNNRPFQICPFDPO-UHFFFAOYSA-N octacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCO CNNRPFQICPFDPO-UHFFFAOYSA-N 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- 229960002666 1-octacosanol Drugs 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- PXRKCOCTEMYUEG-UHFFFAOYSA-N 5-aminoisoindole-1,3-dione Chemical compound NC1=CC=C2C(=O)NC(=O)C2=C1 PXRKCOCTEMYUEG-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241000693997 Anacardium Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 241000133570 Berberidaceae Species 0.000 description 1
- 241000202726 Bupleurum Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 102400000739 Corticotropin Human genes 0.000 description 1
- 101800000414 Corticotropin Proteins 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 244000040122 Elsholtzia pubescens Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000893536 Epimedium Species 0.000 description 1
- 241000424773 Epimedium alpinum Species 0.000 description 1
- 241001362411 Epimedium sagittatum Species 0.000 description 1
- 241001362415 Epimedium wushanense Species 0.000 description 1
- 206010070840 Gastrointestinal tract irritation Diseases 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 240000007313 Tilia cordata Species 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 150000007516 brønsted-lowry acids Chemical class 0.000 description 1
- 150000007528 brønsted-lowry bases Chemical class 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 229960000258 corticotropin Drugs 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 229940088592 immunologic factor Drugs 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- REJLGAUYTKNVJM-SGXCCWNXSA-N tomatine Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4C[C@H]5[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@@H]([C@@]1(NC[C@@H](C)CC1)O5)C)[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O REJLGAUYTKNVJM-SGXCCWNXSA-N 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/40—Effervescence-generating compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种果蔬多维保健泡腾片,制成泡腾片的各组分及其重量份数为:保健成分10-25份、崩解剂20-40份、填充剂10-20份、润滑剂2-4份;其中:制成保健成分的原料及其重量份数为:番茄10-20份、银耳6-12份、猕猴桃10-20份、柴胡10-20份、紫河车3-7份、淫羊藿3-7份、枸杞子8-16份、狗胆3-5份、千里光4-12份、甘草4-10份、淮山药10-20份、红枣6-12份、椴树蜜8-16份、葡萄柚4-10份、腰果4-10份、小麦胚芽粉6-12份。本发明制得的泡腾片不含防腐剂,能增强机体免疫力,清肝明目,补充人体必需的各种维生素、矿物质。
Description
技术领域
本发明属于保健食品领域,具体涉及一种果蔬多维保健泡腾片,本发明还涉及该泡腾片的制备方法。
背景技术
随着生活水平提高和社会活动节奏的加快,精神压力、工作压力、环境污染与生活方式不佳,缺乏运动,传统非健康烹调方式,造成饮食作息无规律,使维生素、矿物质和抗氧化物质面临着缺乏,造成人体免疫力下降。相比之下,口服营养补充剂是一种有效的方法,不仅可以预防和改善人体的营养缺乏状态,还可以降低产生某些疾病的危险性。但是现有的果汁饮料含有防腐剂,多喝对健康不利,若能够提供一种适合平时饮用的饮料,既能解渴,又能补充身体必须的维生素,则会广大人群带来更多健康。
泡腾片是以适宜的酸和碱为崩解剂制成的一种片剂。泡腾片入水后会产生大量二氧化碳气体从而迅速溶解,药物起效迅速,易于吞服,对胃肠道刺激性小,生物利用度高,携带方便,故近年发展较快。
因此,研究开发一种可快速补充营养素、提高人体免疫力的多维矿物复合泡腾片是目前研究较多的课题。
发明内容
本发明的目的是提供一种果蔬多维保健泡腾片及其制备方法,制得的泡腾片不含防腐剂,能增强机体免疫力,清肝明目,补充人体必需的各种维生素、矿物质。
本发明解决上述问题所采用的技术方案是:
一种果蔬多维保健泡腾片,制成泡腾片的各组分及其重量份数为:保健成分10-25份、崩解剂20-40份、填充剂10-20份、润滑剂2-4份;其中:
制成保健成分的原料及其重量份数为:番茄10-20份、银耳6-12份、猕猴桃10-20份、柴胡10-20份、紫河车3-7份、淫羊藿3-7份、枸杞子8-16份、狗胆3-5份、千里光4-12份、甘草4-10份、淮山药10-20份、红枣6-12份、椴树蜜8-16份、葡萄柚4-10份、腰果4-10份;
所述崩解剂包括酸剂、碱剂,所述酸剂与碱剂的摩尔比为1-1.2:1。
进一步的,制成泡腾片的各组分及其重量份数为:保健成分18份、崩解剂30份、填充剂15份、润滑剂3份;其中:
制成保健成分的原料及其重量份数为:番茄15份、银耳9份、猕猴桃15份、柴胡15份、紫河车5份、淫羊藿5份、枸杞子12份、狗胆4份、千里光8份、甘草7份、淮山药15份、红枣9份、椴树蜜12份、葡萄柚7份、腰果7份;
所述崩解剂包括酸剂、碱剂,所述酸剂与碱剂的摩尔比为1.1:1。
进一步的,所述保健成分还包括小麦胚芽粉6-12份。
进一步的,所述酸剂为酒石酸、苹果酸、无水柠檬酸、柠檬酸及柠檬酸钠中的一种或几种,碱剂为碳酸钠、碳酸氢钠中的一种。
进一步的,所述润滑剂为聚乙二醇4000、聚乙二醇6000或月桂醇硫酸镁的一种或几种。
进一步的,所述填充剂为乳糖、蔗糖、葡萄糖、甘露醇中的一种。
所述的果蔬多维保健泡腾片的制备方法,包括以下步骤:
(1)将银耳、柴胡、紫河车、淫羊藿、枸杞子、狗胆、千里光、甘草、红枣以水为溶剂,加热提取两次;第一次加入相当于上述药材重量6倍的水,提取2h;第二次加入4倍量的水,提取1h;两次水提液趁热过滤,合并滤液,将上述所得滤液浓缩至药液体积与药材重量比为1:1.2-2,然后进行喷雾干燥,得到膨松的浸膏粉;
(2)准备好新鲜的、无破损的番茄、猕猴桃、淮山药、葡萄柚,将淮山药、猕猴桃、葡萄柚去皮,与沙棘、切成小块的胡萝卜混合,一起送入研磨机进行研磨,将所得汁液进行喷雾干燥并粉碎过325目筛,得到果蔬粉;
(3)将椴树蜜烘干,与腰果共同进行超微粉碎,得到腰果粉;
(4)将浸膏粉、果蔬粉混合均匀,再与酸剂、1/2量的填充剂混合均匀,加入无水乙醇制软材,过20目筛制湿粒,70℃干燥至水分≤1.5%,过30目筛整粒;
(5)将润滑剂用无水乙醇溶解,并加入小麦胚芽粉、剩余1/2量的填充剂、步骤(3)制得的腰果粉和碱剂混合均匀,喷雾干燥过筛整粒备用;
(6)将步骤(4)与步骤(5)分别制备的整粒进行混合,并用压片机进行压片,1g±0.05g/片,并用铝膜进行包装,即得所述的泡腾片。
进一步的,所述泡腾片的形状为圆环形。
本发明的配方中,番茄:含苹果酸、柠檬酸和糖类,番茄富含胡萝卜素、维生素C、维生素B以及维生素B2和钙、磷、钾、镁、铁、锌、铜和碘等多种元素,还含有蛋白质、糖类、有机酸、纤维素。番茄含的“番茄素”,有抑制细菌的作用;番茄中含有丰富的抗氧化剂,可以防止自由基对皮肤的破坏,具有明显的美容抗皱的效果。番茄还具有止血、降压、利尿、健胃消食、生津止渴、清热解毒、凉血平肝的功效;银耳:味甘、淡、性平、无毒,既有补脾开胃的功效,又有益气清肠、滋阴润肺的作用。既能增强人体免疫力,又可增强肿瘤患者对放、化疗的耐受力。银耳富有天然植物性胶质,外加其具有滋阴的作用,是可以长期服用的良好润肤食品;猕猴桃:酸、甘,寒,调中理气,生津润燥,解热除烦。可生食,或去皮后和蜂蜜煎汤服。用于消化不良,食欲不振,呕吐,烧烫伤。能增白、淡斑、除暗疮、排毒抗衰老,增强免疫功能,猕猴桃被认为是一种免疫辅助剂,主要是由于其含有大量的VC和抗氧化物质;柴胡:入药部位为伞形科植物柴胡或狭叶柴胡的干燥根。味辛、苦,性微寒。归肝、胆、肺经。和解表里,疏肝解郁,升阳举陷,退热截疟。用于感冒发热,寒热往来,胸胁胀痛,月经不调,子宫脱垂,脱肛;紫河车:指人类的胎盘。甘咸、温。补气,养血,益精。主治虚损、羸瘦、咳血气喘、劳热骨蒸、遗精等症。现代医学研究认为,胎盘含蛋白质、糖、钙、维生素、免疫因子、女性激素、助孕酮、类固醇激素、促性腺激素、促肾上腺皮质激素等,能促进乳腺、子宫、阴道、睾丸的发育,对甲状腺也有促进作用;淫羊藿:入药部位为小檗科植物淫羊藿、箭叶淫羊藿、柔毛淫羊藿、巫山淫羊藿、或朝鲜淫羊藿的干燥地上部分。辛、甘、温。归肝、肾经。补肾阳,强筋骨,祛风湿。用于阳痿遗精,筋骨痿软,风湿痹痛,麻木拘挛;更年期高血压;枸杞子:为茄科植物枸杞的成熟果实。甘,平。归肝、肾经。滋补肝肾,益精明目。用于肝肾阴虚证。本品甘平质润,平补肝肾,有滋补强壮作用,凡肝肾阴虚诸证均可应用;狗胆:犬科动物狗的胆囊,归肝经。有清肝明目,止血活血的功效。主治风热眼痛,目赤涩痒,吐血,鼻衄,聤耳,疮疡疥癣;千里光:入药部位为菊科植物千里光的干燥地上部分。苦,寒。归肺、肝经。清热解毒,明目,利湿。主治痈肿疮毒,感冒发热,目赤肿痛,泄泻痢疾,皮肤湿疹;甘草:药部位为豆科植物甘草、胀果甘草或光果甘草的干燥根和根茎。味甘,性平。归心、肺、脾、胃经。补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药。用于脾胃虚弱,倦怠乏力,心悸气短,咳嗽痰多,脘腹、四肢挛急疼痛,痈肿疮毒,缓解药物毒性、烈性;淮山药:淮山药作为高营养食品含有大量蛋白质、糖类、B族维生素、维生素C、维生素E、葡萄糖、粗蛋白氨基酸、胆汁碱、尿囊素、及碘、钙、铁、磷等人体不可缺少的无机盐和微量元素等营养成分。味甘,性平。归脾,肺,肾经。补脾养胃,生津益肺,补肾涩精,清热解毒。主治脾虚食少、久泻不止、肺虚喘咳、肾虚遗精、带下、尿频、虚热消渴;红枣:味甘性温、归脾胃经,有补中益气、养血安神、缓和药性、能提高人体免疫力的功能;而现代的药理学则发现,红枣含有蛋白质、脂肪、糖类、有机酸、维生素A、维生素C、多种微量钙以及氨基酸等丰富的营养成份;棒棒草:药源基础为石竹科植物短小孩儿参的干燥块根。甘,苦,微温。补肺;健脾;养阴生津。主治肺虚咳嗽,脾虚食少,心悸自汗,疲惫乏力,口干;椴树蜜:椴花蜜色泽晶莹,色为浅琥珀色,醇厚甘甜。具浓郁的椴树花香味,味道甜润适口。用其入药,有补中益气、止咳、润肠、解毒、助消化等功能;另外,色纯味香,营养丰富,含葡萄糖和果酸70%以上,还有多种维生素和无机盐、有机酸酶,有促进人体生长和活力的生物素,能增进健康。它不仅是营养齐全的食品,还能益气补肾、止痛解毒,有医治和减轻高血压、心脏病、便秘、失眠等多种疾病的功效;葡萄柚:葡萄柚含有丰富的营养成分,是集预防疾病及保健与美容于一身的水果。其果肉柔嫩,多汁爽口,略有香气,味偏酸、带苦味及麻舌味。其果汁略有苦味,但口感舒适,含有宝贵的天然维生素P和丰富的维生素C以及可溶性纤维素,还能帮助人体吸收钙和铁质。葡萄柚酸性物质可以帮助消化液的增加,借此促进消化功能,而且营养也容易被吸收。大约一颗葡萄柚就有100毫克,不仅可以消除疲劳,还可以美化肌肤,含糖份少使得减肥时可用来补充维他命C;腰果:是一种肾形坚果,无患子目漆树科腰果属。有丰富的营养价值,可炒菜,也可作药用。它的营养十分丰富,含脂肪高达47%,蛋白质21.2%,碳水化合物22.3%,尚含A、B1、B2等多种维生素和矿物质,特别是其中的锰、铬、镁、硒等微量元素,具有抗氧化、防衰老、抗肿瘤和抗心血管病的作用。而所含之脂肪多为不饱和脂肪酸,其中油酸占总脂肪酸的67.4%,亚油酸占19.8%,是高血脂、冠心病患者的食疗佳果。经常食用腰果有强身健体、提高机体抗病能力、增进性欲、增加体重等作用。中医学认为,腰果味甘,性平,无毒。可治咳逆、心烦、口渴。《本草拾遗》云:腰果仁主治渴、润肺、去烦、除痰。《海药本草》亦云:主烦躁、心闷、痰鬲、伤寒清涕、咳逆上气;小麦胚芽粉:小麦胚芽是从优质小麦粒中萃取的精华,是一种高蛋白、高维生素E、低热、低脂、低胆固醇的营养品。含有维生素B族、维生素D、不饱和脂肪酸、核酸、叶酸、二十八烷醇和钙、铁、锌、硒等10余种矿物质等,是非常理想的微量金属元素的供给源,是“天然维生素E的仓库”,是“人类的天然营养宝库”。能提高肌体免疫能力,保持血红细胞的完整性,调节体内化合物的合成,促进血红细胞的生物合成。
本发明的有益效果是:
(1)本发明针对现代人们快节奏的生活,压力大,缺乏运动,使维生素、矿物质和抗氧化物质面临着缺乏,造成人体免疫力下降的现状,发明了一种果蔬多维泡腾片,制得的泡腾片将多种具有不同功效的天然成分组合到一起,不添加防腐剂,通过简单的工艺进行复配,具有增强机体免疫力,清肝明目,补充人体必需的各种维生素和微量元素的作用,从根本上调理身体,给广大人群带来健康。
(2)本发明的泡腾片以天然的果蔬为主要活性成分,并添加几味性温的中草药,果蔬与中草药相互配合,使人们在补充各种营养元素的同时,使机体增强自身的免疫能力,清肝明目,强身健体;
(3)本发明的泡腾片不添加其他矫味剂,其添加的果蔬成分本身具有的气味既作为活性成分,又可以充当矫味剂来改善泡腾片的气味,且本发明的泡腾片设计成环形,释放活性成分速度快,生物利用度高,冲泡方便,特别适用于儿童、老年人以及工作人群使用。
具体实施方式
下面将结合本发明的实施例,对本发明的技术方案进行清楚、完整地描述。
实施例1
一种果蔬多维保健泡腾片,制成泡腾片的各组分及其重量份数为:保健成分10份、崩解剂20份、填充剂10份、润滑剂2份;其中:
制成保健成分的原料及其重量份数为:番茄10份、银耳6份、猕猴桃10份、柴胡10份、紫河车3份、淫羊藿3份、枸杞子8份、狗胆3份、千里光4份、甘草4份、淮山药10份、红枣6份、椴树蜜8份、葡萄柚4份、腰果4份、小麦胚芽粉6份;
所述崩解剂包括柠檬酸、苹果酸、碳酸氢钠,所述(柠檬酸+苹果酸)与碳酸氢钠的摩尔比为1:1;
所述润滑剂为聚乙二醇6000。
所述填充剂为乳糖。
所述的果蔬多维保健泡腾片的制备方法,包括以下步骤:
(1)将银耳、柴胡、紫河车、淫羊藿、枸杞子、狗胆、千里光、甘草、红枣以水为溶剂,加热提取两次;第一次加入相当于上述药材重量6倍的水,提取2h;第二次加入4倍量的水,提取1h;两次水提液趁热过滤,合并滤液,将上述所得滤液浓缩至药液体积与药材重量比为1:1.2-2,然后进行喷雾干燥,得到膨松的浸膏粉;
(2)准备好新鲜的、无破损的番茄、猕猴桃、淮山药、葡萄柚,将淮山药、猕猴桃、葡萄柚去皮,与沙棘、切成小块的胡萝卜混合,一起送入研磨机进行研磨,将所得汁液进行喷雾干燥并粉碎过325目筛,得到果蔬粉;
(3)将椴树蜜烘干,与腰果共同进行超微粉碎,得到腰果粉;
(4)将浸膏粉、果蔬粉混合均匀,再与酸剂、1/2量的填充剂混合均匀,加入无水乙醇制软材,过20目筛制湿粒,70℃干燥至水分≤1.5%,过30目筛整粒;
(5)将润滑剂用无水乙醇溶解,并加入小麦胚芽粉、剩余1/2量的填充剂、步骤(3)制得的腰果粉和碱剂混合均匀,喷雾干燥过筛整粒备用;
(6)将步骤(4)与步骤(5)分别制备的整粒进行混合,并用压片机的环形片磨具进行压片,1g±0.05g/片,即得环形的泡腾片。
实施例2
一种果蔬多维保健泡腾片,制成泡腾片的各组分及其重量份数为:保健成分25份、崩解剂40份、填充剂20份、润滑剂4份;其中:
制成保健成分的原料及其重量份数为:番茄20份、银耳12份、猕猴桃20份、柴胡20份、紫河车7份、淫羊藿7份、枸杞子16份、狗胆5份、千里光12份、甘草10份、淮山药20份、红枣12份、椴树蜜16份、葡萄柚10份、腰果10份、小麦胚芽粉12份;
所述崩解剂包括柠檬酸钠、苹果酸、碳酸钠,所述(柠檬酸钠+苹果酸)与碳酸钠的摩尔比为1.2:1;
所述润滑剂为聚乙二醇4000与月桂醇硫酸镁;
所述填充剂为甘露醇。
本实施例的泡腾片的制备方法同实施例的泡腾片的制备方法相同。
实施例3
一种果蔬多维保健泡腾片,制成泡腾片的各组分及其重量份数为:保健成分18份、崩解剂30份、填充剂15份、润滑剂3份;其中:
制成保健成分的原料及其重量份数为:番茄15份、银耳9份、猕猴桃15份、柴胡15份、紫河车5份、淫羊藿5份、枸杞子12份、狗胆4份、千里光8份、甘草7份、淮山药15份、红枣9份、椴树蜜12份、葡萄柚7份、腰果7份、小麦胚芽粉9份;
所述崩解剂包括柠檬酸、碳酸氢钠,所述柠檬酸与碳酸氢钠的摩尔比为1.1:1;
所述润滑剂为聚乙二醇6000;
所述填充剂为乳糖。
本实施例的泡腾片的制备方法同实施例的泡腾片的制备方法相同。
比较例
一种果蔬多维保健泡腾片,制成泡腾片的各组分及其重量份数为:保健成分18份、崩解剂30份、填充剂15份、润滑剂3份;其中:
制成保健成分的原料及其重量份数为:番茄15份、银耳9份、猕猴桃15份、柴胡15份、紫河车5份、淫羊藿5份、枸杞子12份、狗胆4份、千里光8份、甘草7份、淮山药15份、红枣9份、椴树蜜12份、葡萄柚7份、腰果7份、小麦胚芽粉9份;
所述崩解剂包括柠檬酸、碳酸氢钠,所述柠檬酸与碳酸氢钠的摩尔比为1.1:1;
所述润滑剂为聚乙二醇6000;
所述填充剂为乳糖。
所述的果蔬多维保健泡腾片的制备方法,包括以下步骤:
(1)将银耳、柴胡、紫河车、淫羊藿、枸杞子、狗胆、千里光、甘草、红枣以水为溶剂,加热提取两次;第一次加入相当于上述药材重量6倍的水,提取2h;第二次加入4倍量的水,提取1h;两次水提液趁热过滤,合并滤液,将上述所得滤液浓缩至药液体积与药材重量比为1:1.2-2,然后进行喷雾干燥,得到膨松的浸膏粉;
(2)准备好新鲜的、无破损的番茄、猕猴桃、淮山药、葡萄柚,将淮山药、猕猴桃、葡萄柚去皮,与沙棘、切成小块的胡萝卜混合,一起送入研磨机进行研磨,将所得汁液进行喷雾干燥并粉碎过325目筛,得到果蔬粉;
(3)将椴树蜜烘干,与腰果共同进行超微粉碎,得到腰果粉;
(4)将浸膏粉、果蔬粉混合均匀,再与酸剂、1/2量的填充剂混合均匀,加入无水乙醇制软材,过20目筛制湿粒,70℃干燥至水分≤1.5%,过30目筛整粒;
(5)将润滑剂用无水乙醇溶解,并加入小麦胚芽粉、剩余1/2量的填充剂、步骤(3)制得的腰果粉和碱剂混合均匀,喷雾干燥过筛整粒备用;
(6)将步骤(4)与步骤(5)分别制备的整粒进行混合,并用压片机的圆形实心片磨具进行压片,1g±0.05g/片,即得圆形实心的泡腾片。
一、崩解时限实验
以实施例3和比较例制成的两种泡腾片进行崩解时限实验。
泡腾片形状 | 实施例3制备环形泡腾片 | 比较例制备圆形实心泡腾片 |
崩解时间 | 148s | 257s |
从试验数据可知,两种形状的泡腾片崩解时限均符合中国药典2010版二部小于5分钟的要求,但环形泡腾片崩解更为迅速,给使用者带来更大的方便。
二、动物毒性实验
为了试验本发明泡腾片长期使用对身体无危害,我们还做了动物长期毒性试验,具体步骤如下:
健康成年小鼠10只,体重18-22g,将本发明的泡腾片溶解后拌在饲料中给小鼠喂养,小鼠食用量为10片/天,连续喂养8周,停药3周后对小鼠的毛发、行为、大小便、体重、脏器重量、血象、肝肾功能、血糖、血脂进行检测,试验小鼠的毛发、行为、大小便、体重、脏器重量、血象、肝肾功能、血糖、血脂等指标均无明显影响,脏器肉眼没有发现异样变化。组织学检查结果表明,用药8周及停药3周后,小鼠各脏器均无明显改变,说明本发明对小鼠长期用药后毒性小,停药后也没有异样反应,应用安全。
三、泡腾片各项成分检测
维生素A、E的测定按照食GB5413.9-2010进行。
维生素C的测定按照GB5413.18-2010进行。
胡萝卜素的测定按照GB/T5009.83-2003进行。
钙的测定按照GB/T5009.92-2003进行。
100片泡腾片中维生素A、C、D、E、钙、胡萝卜素、锌的检测结果:泡腾片的检测结果如表2所示。
表2泡腾片的检测结果
维生素A | 维生素C | 维生素E | 钙 | 胡萝卜素 | 锌 | |
实施例1 | 33.5mg | 9.2mg | 9.8mg | 20.7mg | 290μg | 21.3mg |
实施例2 | 34.6mg | 9.6mg | 10.1mg | 21.4mg | 308μg | 21.9mg |
实施例3 | 34.5mg | 9.9mg | 10.0mg | 21.5mg | 289μg | 21.2mg |
通过检测结果可以看出本发明的泡腾片的营养成分维生素A、C、E、钙、胡萝卜素、锌的含量比较高,富含多种营养成分,可以放心食用。
以上所述是本发明的优选实施方式,其目的在于让熟悉此项技术的人了解本发明内容并加以实施,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也视为本发明的保护范围。
Claims (8)
1.一种果蔬多维保健泡腾片,其特征在于,制成泡腾片的各组分及其重量份数为:保健成分10-25份、崩解剂20-40份、填充剂10-20份、润滑剂2-4份;其中:
制成保健成分的原料及其重量份数为:番茄10-20份、银耳6-12份、猕猴桃10-20份、柴胡10-20份、紫河车3-7份、淫羊藿3-7份、枸杞子8-16份、狗胆3-5份、千里光4-12份、甘草4-10份、淮山药10-20份、红枣6-12份、椴树蜜8-16份、葡萄柚4-10份、腰果4-10份;
所述崩解剂包括酸剂、碱剂,所述酸剂与碱剂的摩尔比为1-1.2:1。
2.如权利要求1所述的一种果蔬多维保健泡腾片,其特征在于,制成泡腾片的各组分及其重量份数为:保健成分18份、崩解剂30份、填充剂15份、润滑剂3份;其中:
制成保健成分的原料及其重量份数为:番茄15份、银耳9份、猕猴桃15份、柴胡15份、紫河车5份、淫羊藿5份、枸杞子12份、狗胆4份、千里光8份、甘草7份、淮山药15份、红枣9份、椴树蜜12份、葡萄柚7份、腰果7份;
所述崩解剂包括酸剂、碱剂,所述酸剂与碱剂的摩尔比为1.1:1。
3.如权利要求1或2所述的一种果蔬多维保健泡腾片,其特征在于,所述保健成分还包括小麦胚芽粉6-12份。
4.如权利要求1或2所述的一种果蔬多维保健泡腾片,其特征在于,所述酸剂为酒石酸、苹果酸、无水柠檬酸、柠檬酸及柠檬酸钠中的一种或几种,碱剂为碳酸钠、碳酸氢钠中的一种。
5.如权利要求1或2所述的一种果蔬多维保健泡腾片,其特征在于,所述润滑剂为聚乙二醇4000、聚乙二醇6000或月桂醇硫酸镁的一种或几种。
6.如权利要求1或2所述的一种果蔬多维保健泡腾片,其特征在于,所述填充剂为乳糖、蔗糖、葡萄糖、甘露醇中的一种。
7.一种权利要求3所述的果蔬多维保健泡腾片的制备方法,其特征在于,包括以下步骤:
(1)将银耳、柴胡、紫河车、淫羊藿、枸杞子、狗胆、千里光、甘草、红枣以水为溶剂,加热提取两次;第一次加入相当于上述药材重量6倍的水,提取2h;第二次加入4倍量的水,提取1h;两次水提液趁热过滤,合并滤液,将上述所得滤液浓缩至药液体积与药材重量比为1:1.2-2,然后进行喷雾干燥,得到膨松的浸膏粉;
(2)准备好新鲜的、无破损的番茄、猕猴桃、淮山药、葡萄柚,将淮山药、猕猴桃、葡萄柚去皮,与沙棘、切成小块的胡萝卜混合,一起送入研磨机进行研磨,将所得汁液进行喷雾干燥并粉碎过325目筛,得到果蔬粉;
(3)将椴树蜜烘干,与腰果共同进行超微粉碎,得到腰果粉;
(4)将浸膏粉、果蔬粉混合均匀,再与酸剂、1/2量的填充剂混合均匀,加入无水乙醇制软材,过20目筛制湿粒,70℃干燥至水分≤1.5%,过30目筛整粒;
(5)将润滑剂用无水乙醇溶解,并加入小麦胚芽粉、剩余1/2量的填充剂、步骤(3)制得的腰果粉和碱剂混合均匀,喷雾干燥过筛整粒备用;
(6)将步骤(4)与步骤(5)分别制备的整粒进行混合,并用压片机进行压片,1g±0.05g/片,并用铝膜进行包装,即得所述的泡腾片。
8.如权利要求7所述的预防口腔溃疡的泡腾片的制备方法,其特征在于,所述泡腾片的形状为圆环形。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510542106.9A CN105231247A (zh) | 2015-08-31 | 2015-08-31 | 一种果蔬多维保健泡腾片及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510542106.9A CN105231247A (zh) | 2015-08-31 | 2015-08-31 | 一种果蔬多维保健泡腾片及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105231247A true CN105231247A (zh) | 2016-01-13 |
Family
ID=55029311
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510542106.9A Pending CN105231247A (zh) | 2015-08-31 | 2015-08-31 | 一种果蔬多维保健泡腾片及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105231247A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106071527A (zh) * | 2016-06-08 | 2016-11-09 | 佛山泓乾生物科技有限公司 | 一种木瓜复合醋饮料及其制作方法 |
CN106071526A (zh) * | 2016-06-08 | 2016-11-09 | 佛山泓乾生物科技有限公司 | 一种保健饮料及其制作方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1615918A (zh) * | 2003-11-13 | 2005-05-18 | 上海华拓医药科技发展有限公司 | 一种中药泡腾片及其制备方法 |
CN1788605A (zh) * | 2004-12-15 | 2006-06-21 | 许明昆 | 果蔬泡腾片及其制备方法 |
CN101352255A (zh) * | 2007-07-26 | 2009-01-28 | 刘洪生 | 枸杞营养泡腾饮片及其制造工艺 |
CN101965969A (zh) * | 2009-07-28 | 2011-02-09 | 成都自豪药业有限公司 | 一种具有抗疲劳和提高免疫功能保健食品组合物及其制备方法和用途 |
CN102048168A (zh) * | 2009-11-03 | 2011-05-11 | 胥永贵 | 杞枣复合矿物质维生素 |
CN102150861A (zh) * | 2011-02-15 | 2011-08-17 | 辽宁盛生医药集团有限公司 | 一种具有抗氧化、抗疲劳功能的营养补充剂 |
CN102178830A (zh) * | 2010-12-08 | 2011-09-14 | 叶建斌 | 降火泡腾片的配方及其制备方法 |
CN102233057A (zh) * | 2010-05-05 | 2011-11-09 | 陈云英 | 一种健身族保健泡腾片 |
-
2015
- 2015-08-31 CN CN201510542106.9A patent/CN105231247A/zh active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1615918A (zh) * | 2003-11-13 | 2005-05-18 | 上海华拓医药科技发展有限公司 | 一种中药泡腾片及其制备方法 |
CN1788605A (zh) * | 2004-12-15 | 2006-06-21 | 许明昆 | 果蔬泡腾片及其制备方法 |
CN101352255A (zh) * | 2007-07-26 | 2009-01-28 | 刘洪生 | 枸杞营养泡腾饮片及其制造工艺 |
CN101965969A (zh) * | 2009-07-28 | 2011-02-09 | 成都自豪药业有限公司 | 一种具有抗疲劳和提高免疫功能保健食品组合物及其制备方法和用途 |
CN102048168A (zh) * | 2009-11-03 | 2011-05-11 | 胥永贵 | 杞枣复合矿物质维生素 |
CN102233057A (zh) * | 2010-05-05 | 2011-11-09 | 陈云英 | 一种健身族保健泡腾片 |
CN102178830A (zh) * | 2010-12-08 | 2011-09-14 | 叶建斌 | 降火泡腾片的配方及其制备方法 |
CN102150861A (zh) * | 2011-02-15 | 2011-08-17 | 辽宁盛生医药集团有限公司 | 一种具有抗氧化、抗疲劳功能的营养补充剂 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106071527A (zh) * | 2016-06-08 | 2016-11-09 | 佛山泓乾生物科技有限公司 | 一种木瓜复合醋饮料及其制作方法 |
CN106071526A (zh) * | 2016-06-08 | 2016-11-09 | 佛山泓乾生物科技有限公司 | 一种保健饮料及其制作方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102160573A (zh) | 一种代餐奶昔及其制备方法 | |
CN102138671A (zh) | 一种人参八珍保健糕的配方和制成方法 | |
CN102986887A (zh) | 一种养生风味奶昔及其制备方法 | |
CN109966417A (zh) | 一种针对糖尿病人群的固体饮料 | |
CN107183290A (zh) | 一种黑枸杞压片糖果及其制备方法 | |
CN109662253A (zh) | 一种具有食疗功能的面条及其制备方法 | |
CN102940219B (zh) | 一种土豆饼及其制作方法 | |
CN108813501A (zh) | 具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏 | |
CN104312875A (zh) | 一种小米滋补酒的制备方法 | |
KR20160000695A (ko) | Dha 함유 기억력 강화 및 피로회복 증진용 한약재 조성물 수능환 및 그 제조방법 | |
CN105231247A (zh) | 一种果蔬多维保健泡腾片及其制备方法 | |
CN106605832A (zh) | 一种果蔬养颜米粉及其制备方法 | |
CN104187714B (zh) | 一种高丽红参膳食纤维膨化粉的制备方法 | |
CN107950862A (zh) | 一种红枣羹及其制作方法 | |
CN106107277A (zh) | 一种油桃饮料及其制备方法 | |
CN105285976A (zh) | 具有保健功能的食品颗粒剂及其用途 | |
CN109452417A (zh) | 一种纯天然清脂减肥茶饮料及其制备方法 | |
CN104543999A (zh) | 一种猴头菇健胃消食汤料的配方及生产方法 | |
CN113841884A (zh) | 改善营养代谢的速溶代餐粉配方及其制作方法 | |
CN103610050B (zh) | 一种含有红椎菌的营养膏及其制作方法 | |
CN105079391A (zh) | 一种预防口腔溃疡的泡腾片及其制备方法 | |
CN105146392A (zh) | 一种营养奶昔粉及其制备方法 | |
CN105875903A (zh) | 一种以山楂果为主要原料的茶制品及其制备方法 | |
CN104187662A (zh) | 一种调理卵巢癌的方便食品 | |
CN108552432A (zh) | 一种提高蛋鸡产蛋率的蛋鸡饲料及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160113 |
|
RJ01 | Rejection of invention patent application after publication |